Registro:

Referencias:

• Agarwal, A., Expression of HSDIIK (NAD+dependent IIbeta-hydroxysteroid dehydrogenase) promoter constructs in renal cell lines (2000) Endocr Res, 26, pp. 289-302
• Akana, S., Dallman, M., Chronic cold in adrenalectomized, corticosterone (B)-treated rats: Facilitated corticotropin responses to acute restraint emerge as B increases (1997) Endocrinology, 138, pp. 3249-3258
• Alfaidy, N., Blot-Chabaud, M., Robic, D., Kenouch, S., Bourbouze, R., Bonvalet, J., Farman, N., Characteristics and regulation of 11 beta-hydroxysteroid dehydrogenase of proximal and distal nephron (1995) Biochem Bioph Acta, 1243, pp. 461-468
• Alfaidy, N., Blot-Chabaud, M., Bonvalet, J., Farman, N., Vasopressin potentiates mineralocorticoid selectivity by stimulating 11β-hydroxysteroid dehydrogenase in rat collecting duct (1997) J Clin Invest, 100, pp. 2437-2442
• Arriza, J., Weinberger, C., Cerelli, G., Glaser, T., Handelin, B., Housman, D., Evans, R., Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor (1987) Science, 237, pp. 268-275
• Audigé, A., Dick, B., Frey, B., Frey, M., Corman, B., Vogt, B., Glucocorticoids and 11β-hydroxysteroid dehydrogenase type 2 gene expression in the aging kidney (2002) Eur J Clin Invest, 32, pp. 411-420
• Bonvalet, J., Doignon, I., Blot-Chabaud, M., Pradelles, P., Farman, N., Distribution of 11β-hydroxysteroid dehydrogenase along the rabbit nephron (1990) J Clin Invest, 86, pp. 832-837
• Bradford, M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding (1976) Ann Biochem, 72, pp. 248-254
• Brooks, H.L., Ageloff, S., Kwon, T.H., Brandt, W., Terris, J.M., Seth, A., Michea, L., Knepper, M.A., DNA array identification of genes regulated in rat renal medulla in response to vasopressin infusion (2003) Am J Physiol Renal Physiol, 284, pp. F218-F228
• Carlton, B.D., Barlett, P., Basaran, A., Colling, K., Osis, I., Smith, M.K., Reproductive effects of alternative disinfectants (1986) Environ Health Perspect, 69, pp. 237-241
• Chen, K., Suh, J., Carr, A.C., Morrow, J.D., Zeind, J., Frei, B., Vitamin C suppresses oxidative lipid damage in vivo, even in the presence of iron overload (2000) Am J Physiol Endocrinol Metab, 279, pp. E1406-E1412
• Dallman, M., Akana, S., Cascio, C., Darlington, D., Jacobson, L., Levin, N., Regulation of ACTH secretion: Variations on a theme of B (1987) Recent Prog Horm Res, 43, pp. 113-173
• Damasco, M.C., Coronel De Pedazzini, M., Corticosterone secretion by rats after adrenalectomy (1985) Acta Physiol Pharmacol Latin Am, 35, pp. 415-417
• Damasco, M.C., Díaz, F., Cenal, J., Lantos, C., Acute effects of three natural corticosteroids on the acid-base and electrolyte composition of urine in adrenalectomized rats (1979) Acta Physiol Latinoam, 29, pp. 305-314
• Damasco, M.C., Ansaldo, M., Malnic, G., Effects of adrenalectomy and acute replacement by corticosteroids on distal acidification (1990) Can J Physiol Pharmacol, 67, pp. 607-614
• Darnel, A., Archer, T., Yang, K., Regulation of 11β-hydroxysteroid dehydrogenase type 2 by steroid hormones and epidermal growth factor in the Ishikawa human endometrial cell line (1999) J Steroid Biochem Mol Biol, 70, pp. 203-210
• Diederich, S., Quinkler, M., Miller, K., Heilmann, P., Schoneshofer, M., Oelkers, W., Human kidney 11 beta-hydroxysteroid dehydrogenase: Regulation by adrenocorticotropin? (1996) Eur J Endocrinol, 134, pp. 301-307
• Edwards, C., Stewart, P., Burt, D., Brett, L., McIntyre, M., Sutanto, W., De Kloet, E., Monder, C., Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor (1988) Lancet, 2, pp. 986-989
• Farman, N., Bocchi, B., Mineralocorticoid selectivity: Molecular and cellular aspects (2000) Kidney Int, 57, pp. 1364-1369
• Ferrari, P., Krozowski, Z., Role of the 11β-hydroxysteroid dehydrogenase type 2 in blood pressure regulation (2000) Kidney Int, 57, pp. 1374-1381
• Ferrari, P., Obeyesekere, V., Li, K.X.Z., Aragona, F., Krozowski, Z., The 11 beta-hydroxysteroid dehydrogenase type II enzyme: Biochemical consequences of the congenital R337C mutation (1996) Steroids, 61, pp. 197-200
• Funder, J., Pearce, P., Smith, R., Smith, A., Mineralocorticoid action: Target tissue specificity is enzyme, not receptor mediated (1988) Science, 242, pp. 583-585
• Gomez-Sanchez, E., Gomez-Sanchez, C.E., Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone (1992) Am J Physiol, 263, pp. E1125-E1130
• Gomez-Sanchez, C., Murry, B., Kem, D., Kaplan, N., A direct radioimmunoassay of corticosterone in rat serum (1975) Endocrinology, 96, pp. 796-798
• Gomez-Sanchez, E., Ganjan, V., Chen, Y., Liu, Y., Clark, S., Gomez-Sanchez, C., The 11β-hydroxysteroid dehydrogenase 2 exists as an inactive dimer (2001) Steroids, 66, pp. 845-848
• Hawk, C.T., Li, L., Schafer, J.A., AVP and aldosterone at physiological concentrations have synergistic effects on Na transport in rat CCD (1996) Kidney Int, 50, pp. S35-S41
• Hirasawa, G., Takeyama, J., Sasano, H., Fukushima, K., Suzuki, T., Muramatu, Y., Darnel, A., Krozowski, Z., 11β-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human placenta (2000) J Clin Endocrinol Metab, 85, pp. 1306-1309
• Igarreta, P., Calvo, J.C., Paladini, A., Damasco, C., Acute effects of two natural corticosteroids on the kinetics of the Na+/H+ exchanger in rat renal brush-border membranes (1997) Can J Physiol Pharm, 75, pp. 1226-1231
• Igarreta, P., Lantos, C., Calvo, J.C., Paladini, A., Damasco, C., Dose-dependence of the effects of corticosterone and the non-glucocorticoid 18-hydroxycorticosterone on the brush border Na +/H+ exchanger (1998) Endocr Res, 24, pp. 601-605
• Igarreta, P., Calvo, J.C., Damasco, C., Activity of renal 11βhydroxysteroid dehydrogenase 2 (11BHSD2) in stressed animals (1999) Life Sci, 64, pp. 2285-2290
• Jacobson, H., Kokko, J., Intrarenal heterogeneity: Vascular and tubular (1985) The Kidney: Physiology and Pathophysiology, pp. 531-580. , Seldin D, Giebisch G, editors, New York: Raven Press
• Kotelevtsev, Y., Brown, R., Flemings, Kenyon, C., Edwards, C., Seckl, J., Mullins, J., Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2 (1999) J Clin Invest, 103, pp. 683-689
• Koyama, K., Krozowski, Z., Modulation of 11 beta-hydroxysteroid dehydrogenase type 2 activity in Ishikawa cells is associated with changes in cellular proliferation (2001) Mol Cell Endocrinol, 183, pp. 165-170
• Krozowski, Z., The short-chain alcohol dehydrogenase superfamily: Variations on a common theme (1994) J Steroid Biochem Mol Biol, 51, pp. 125-130
• Krozowski, Z., Funder, J., Renal mineralocorticoid receptors and hippocampal corticosterone binding species have identical intrinsic steroid specificity (1983) Proc Nat Acad Sci USA, 80, pp. 6056-6060
• Kurokawa, K., Cellular mechanisms and sites of hormone action in the kidney (1985) The Kidney: Physiology and Pathophysiology, pp. 739-774. , Seldin D, Giebisch G, editors. New York: Raven Press
• Leckie, C., Chapman, K., Edwards, C., Seckl, J., LLC-PK1 cells model 11βhydroxysteroid dehydrogenase type 2 regulation of glueocorticoid access to renal mineralocorticoid receptors (1995) Endocrinology, 136, pp. 5561-5569
• Li, K.X.Z., Smith, R., Ferrari, P., Funder, J., Krozowski, Z., Rat 11 beta-hydroxysteroid dehydrogenase type 2 enzyme is expressed at low levels in the placenta and is modulated by adrenal steroids in the kidney (1996) Mol Cell Endocrinol, 120, pp. 67-75
• Mantero, F., Palermo, M., Petrelli, M., Tedde, R., Stewart, P., Shackleton, C., Apparent mineralocorticoid excess: Type I and type II (1996) Steroids, 61, pp. 193-196
• Meier, J.R., Bull, R.J., Stober, J.A., Cimino, M.C., Evaluation of chemicals used for drinking water disinfection for production of chromosomal damage and sperm-head abnormalities in mice (1985) Environ Mutagen, 7, pp. 201-211
• Monder, C., Shackleton, C., 11 beta-hydroxysteroid dehydrogenase: Fact or fancy? (1984) Steroids, 44, pp. 383-417
• Monder, C., Stewart, P., Lakshmi, V., Valentino, R., Burt, D., Edwards, C., Licorice inhibits corticosteroid 11 beta-dehydrogenase of rat kidney and liver: In vivo and in vitro studies (1989) Endocrinology, 5, pp. 1046-1053
• Munck, A., Náray-Fejes-Tóth, A., The ups and downs of glucocorticoid physiology. Permissive and suppressive effects revisited (1992) Mol Cell Endocrinol, 90, pp. C1-C4
• Munck, A., Náray-Fejes-Toth, A., Glucocorticoids and stress: Permissive and suppressive actions (1994) Ann NY Acad Sci, 746, pp. 115-130
• Nawrocki, A.R., Goldring, C.E., Kostadinova, R.M., Frey, F.J., Frey, B.M., In vivo footprinting of the human 11β-hydroxysteroid dehydrogenase type 2 promoter (2002) J Biol Chem, 277, pp. 14647-14656
• Obeyesekere, V., Ferrari, P., Andrews, R., Wilson, R., New, M., Funder, J., Krozowski, Z., The R337C mutation generates a high Km 11 beta-hydroxysteroid dehydro-genase type II enzyme in a family with apparent mineralocorticoid excess (1995) J Clin Endocrinol Metab, 80, pp. 3381-3383
• Odermatt, A., Arnold, P., Frey, F., The intracellular localization of the mineralocorticoid receptor is regulated by 11β-hydroxysteroid dehydrogenase type 2 (2001) J Biol Chem, 276, pp. 28484-28492
• Pacak, K., Palkovits, M., Stressor specificity of control neuroendocrine responses: Implication for stress-related disorders (2001) Endocr Rev, 22, pp. 502-548
• Sapolsky, R., Romero, M., Munck, A., How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions (2000) Endocr Rev, 21, pp. 55-89
• Seckl, J.R., Walker, B.R., Minireview: 11β-hydroxysteroid dehydrogenase type 1-A tissue-specific amplifier of glucocorticoid action (2001) Endocrinology, 142, pp. 1371-1376
• Souness, G.W., Morris, D.J., The antinatriuretic and kaliuretic effects of the glucocorticoids corticosterone and cortisol following pretreatment with carbenoxolone sodium (a liquorice derivative) in the adrenalectomized rat (1989) Endocrinology, 124, pp. 1588-1590
• Stewart, P., Krozowski, Z., 11 beta-hydroxysteroid dehydrogenase (1999) Vitam Horm, 57, pp. 249-324
• Suzuki, S., Koyama, K., Darnel, A., Ishibashi, H., Kobayashi, S., Kubo, H., Suzuki, T., Krozowski, Z., Dexamethasone up regulates 11{beta}-hydroxysteroid dehydrogenase type 2 in BEAS-2B cells (2003) Am J Respir Crit Care Med, 167, pp. 1244-1249
• Tanioka, H., Nakamura, K., Fujimura, S., Yoshida, M., Suzuki-Kusaba, M., Hisa, H., Satoh, S., Facilitatory role of NO in neural norepinephrine release in the rat kidney (2002) Am J Physiol: Reg: Integr Comp Physiol, 282, pp. R1436-R1442
• White, P.C., Mune, T., Agarwal, A.K., 11 beta-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess (1997) Endocr Rev, 18, pp. 135-156
• Ye, S., Zhong, H., Yanamadala, V., Campese, V., Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity (2002) Am J Hyper, 15, pp. 717-724

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------